Novel pyrazolo[4,3-d]pyrimidine microtubule targeting agents (MTAs): Synthesis, structure–activity relationship, in vitro and in vivo evaluation as antitumor agents

Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin

Chii M. Lin, Holly H. Ho, George R. Pettit et al. · Biochemistry · 1989 · 414 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients

Gabriella Ferrandina, Gian Franco Zannoni, Enrica Martinelli et al. · Clinical Cancer Research · 2006 · 219 citations · Full text

Medicine, Oncology, Surgery +16

Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy

P. Sève, Sylvie Isaac, Olivier Trédan et al. · Clinical Cancer Research · 2005 · 196 citations

Medicine, Oncology, Pharmacology +13

Class III β-tubulin expression and in vitro resistance to microtubule targeting agents

Chloé Stengel, Stephen T. Newman, Mathew P. Leese et al. · British Journal of Cancer · 2009 · 191 citations · Full text

Medicine, Oncology, Pharmacology +16

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer

Rafael Rosell, Giorgio V. Scagliotti, Kathleen D. Danenberg et al. · Oncogene · 2003 · 185 citations

Medicine, Cancer Biology, Oncology +11